India launches biggest vaccination drive yet against a surging coronavirus | Inquirer News

India launches biggest vaccination drive yet against a surging coronavirus

/ 04:18 PM April 01, 2021

A healthcare worker collects a coronavirus disease (COVID-19) test swab sample from a man as others watch, at a temporary shelter for the homeless in New Delhi, India, March 31, 2021

FILE PHOTO: A healthcare worker collects a coronavirus disease (COVID-19) test swab sample from a man as others watch, at a temporary shelter for the homeless in New Delhi, India, March 31, 2021. REUTERS/Adnan Abidi

NEW DELHI — India opened up its coronavirus inoculation program to people above 45 on Thursday as infections surge, which will delay vaccine exports from the world’s biggest maker of the drug.

The country, with the most number of reported COVID-19 cases after the United States and Brazil, has so far injected 64 million doses and exported nearly as many. This has raised criticism at home as India’s per-capita vaccination figure is much lower than many countries.

Article continues after this advertisement

The government has previously said that people over 45 can register for inoculation from April 1.

FEATURED STORIES

India initially focused on front-like workers, the elderly and those suffering from other health conditions, unlike some richer countries that have made all their adults eligible to get inoculated.

New Delhi says it is working towards that goal, and Health Minister Harsh Vardhan tweeted that there would be no vaccine shortage in the country as it opens up the vaccination program.

Article continues after this advertisement

“Center to continually replenish states’ supplies,” he said on Twitter. “Avoid overstocking and under stocking.”

Article continues after this advertisement

India has already decided to delay big vaccine exports for now, including to the WHO-backed global vaccine alliance COVAX.

Article continues after this advertisement

It is currently using the AstraZeneca vaccine and a shot developed at home by Bharat Biotech, which is struggling to step up supplies. India’s drug regulator is soon expected to approve Russia’s Sputnik V vaccine.

India has reported more than 12 million infections, including a big surge last month. Deaths stand at more than 162,400.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: AstraZeneca, India

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.